|
| PAPERS |
|
| Year : 1995 | Volume
: 41
| Issue : 4 | Page : 95-8 |
The impact of cisplat based chemotherapy on advanced ovarian cancer.
GR Prasad, AV Dalal, HB Tongaonkar, S Chatterjee, MR Kamat
Gynecologic Oncology Service, Tata Memorial Hospital, Parel, Bombay.
Correspondence Address:
G R Prasad
Gynecologic Oncology Service, Tata Memorial Hospital, Parel, Bombay.
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 0010707728 
Cisplatinum based chemotherapy has become the standard treatment for ovarian cancers due to its proved superiority over non-cisplat based regimes. However, the therapeutic impact of cisplat based regimes compared to cheaper non-cisplatinum based regimes is questionable when multiple variables such as residual disease, histologic type, grade are introduced. This report is a study of 110 Stage III ovarian cancer patients from 1985-89, with cisplat (n = 69) and non cisplat (n = 41) based chemotherapy. The results of both regimes with reference to the multiple variable factors are presented. We conclude that cisplat based regimes appear to be superior to non-cisplat based regimes except probably in poorly differentiated ovarian tumors where the results were similar with either regimen.
[FULL TEXT] [PDF]*
|
